Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 8Gastrointestinal 4Breast 4Gynecologic 3Thoracic 2Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Sarcoma 1Myeloid 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Sarcoma 4Gliosarcoma 4Glioblastoma 4Brain Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Oligodendroglioma 2Neoplasm Metastasis 2Melanoma 2Liposarcoma 2Endometrial Neoplasms 2Carcinosarcoma 2Carcinoma, Transitional Cell 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Soft Tissue Neoplasms 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Recurrence 1Prostatic Neoplasms 1Platinum-Refractory Fallopian Tube Carcinoma 1Pharyngeal Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Neurofibromatosis 2 1Neoplasms, Mesothelial 1Neoplasms 1

Interventions

Gemcitabine 4pembrolizumab 3Docetaxel 3Cryosurgery 3Biopsy 3eribulin 2durvalumab 2balstilimab 2atezolizumab 2aflibercept 2Zoledronic Acid 2Trastuzumab 2Taxes 2Specimen Handling 2Radiotherapy 2Radiosurgery 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Letrozole 2Irinotecan 2Gene Expression Profiling 2Fulvestrant 2Cisplatin 2Blood Specimen Collection 2Bevacizumab 2130-nm albumin-bound paclitaxel 2trifluridine tipiracil drug combination 1tremelimumab 1trastuzumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Immunoglobulin G × Sarcoma × Clear all
NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡